Trial site
Tulane Cancer Center
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer4 trials
- Lung cancer3 trials
- Bladder cancer1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- High blood pressure1 trial
- Kidney cancer1 trial
- Liver cirrhosis1 trial
- and 5 more
- Phase
- Phase 33 trials
- Phase 42 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Recruiting3 trials
- Terminated2 trials
- Lead sponsor
- Incyte Corporation2 trials
- Novartis Pharmaceuticals2 trials
- Amgen1 trial
- BeOne Medicines1 trial
- Galectin Therapeutics Inc.1 trial
- and 4 more
Running trials
Recruiting
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Active, not recruiting
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Active, not recruiting
Active, not recruiting
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Melanoma1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Completed
Terminated
A Study of AMG 340 in Subjects With Metastatic Castrate-Resistant Prostate Carcinoma
Terminated
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026